Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220606055087N1Phase 3Completed
Phase 3, randomised, single-blind trial comparing Lidocaine spray with Placebo spray (2 arms). Primary endpoints: Pain during biopsy and Pain after biopsy. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220606055087N1.